332 related articles for article (PubMed ID: 16567755)
1. Intravenously administered vitamin C as cancer therapy: three cases.
Padayatty SJ; Riordan HD; Hewitt SM; Katz A; Hoffer LJ; Levine M
CMAJ; 2006 Mar; 174(7):937-42. PubMed ID: 16567755
[TBL] [Abstract][Full Text] [Related]
2. Vitamin C pharmacokinetics: implications for oral and intravenous use.
Padayatty SJ; Sun H; Wang Y; Riordan HD; Hewitt SM; Katz A; Wesley RA; Levine M
Ann Intern Med; 2004 Apr; 140(7):533-7. PubMed ID: 15068981
[TBL] [Abstract][Full Text] [Related]
3. [Vitamin C in complementary oncology--update 2009].
Gröber U
Med Monatsschr Pharm; 2009 Jul; 32(7):263-7. PubMed ID: 19731754
[TBL] [Abstract][Full Text] [Related]
4. Review of high-dose intravenous vitamin C as an anticancer agent.
Wilson MK; Baguley BC; Wall C; Jameson MB; Findlay MP
Asia Pac J Clin Oncol; 2014 Mar; 10(1):22-37. PubMed ID: 24571058
[TBL] [Abstract][Full Text] [Related]
5. Vitamin C Pharmacokinetics in Critically Ill Patients: A Randomized Trial of Four IV Regimens.
de Grooth HJ; Manubulu-Choo WP; Zandvliet AS; Spoelstra-de Man AME; Girbes AR; Swart EL; Oudemans-van Straaten HM
Chest; 2018 Jun; 153(6):1368-1377. PubMed ID: 29522710
[TBL] [Abstract][Full Text] [Related]
6. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
7. Controlled trials of very high dose folic acid, vitamins B12 and B6, intravenous folinic acid and serine for treatment of hyperhomocysteinemia in ESRD.
Gonin JM; Nguyen H; Gonin R; Sarna A; Michels A; Masri-Imad F; Bommareddy G; Chassaing C; Wainer I; Loya A; Cary D; Barker LF; Assefi A; Greenspan R; Mahoney D; Wilcox CS
J Nephrol; 2003; 16(4):522-34. PubMed ID: 14696754
[TBL] [Abstract][Full Text] [Related]
8. Harm of IV High-Dose Vitamin C Therapy in Adult Patients: A Scoping Review.
Yanase F; Fujii T; Naorungroj T; Belletti A; Luethi N; Carr AC; Young PJ; Bellomo R
Crit Care Med; 2020 Jul; 48(7):e620-e628. PubMed ID: 32404636
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic data support 6-hourly dosing of intravenous vitamin C to critically ill patients with septic shock.
Hudson EP; Collie JT; Fujii T; Luethi N; Udy AA; Doherty S; Eastwood G; Yanase F; Naorungroj T; Bitker L; Abdelhamid YA; Greaves RF; Deane AM; Bellomo R
Crit Care Resusc; 2019 Dec; 21(4):236-42. PubMed ID: 31778629
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of vitamins C, E, and their combination for treatment of restless legs syndrome in hemodialysis patients: a randomized, double-blind, placebo-controlled trial.
Sagheb MM; Dormanesh B; Fallahzadeh MK; Akbari H; Sohrabi Nazari S; Heydari ST; Behzadi S
Sleep Med; 2012 May; 13(5):542-5. PubMed ID: 22317944
[TBL] [Abstract][Full Text] [Related]
11. [Does high-dose intravenous vitamin C has anti-cancer activity ?].
Courtes MG; Baudoux N; Astaras C; Fernandez E
Rev Med Suisse; 2022 May; 18(782):1002-1006. PubMed ID: 35583280
[TBL] [Abstract][Full Text] [Related]
12. Adjunctive intravenous then oral vitamin C for moderate and severe community-acquired pneumonia in hospitalized adults: feasibility of randomized controlled trial.
Chambers ST; Storer M; Scott-Thomas A; Slow S; Williman J; Epton M; Murdoch DR; Metcalf S; Carr A; Isenman H; Maze M
Sci Rep; 2023 Jul; 13(1):11879. PubMed ID: 37482552
[TBL] [Abstract][Full Text] [Related]
13. Chemoprevention of precancerous gastric lesions with antioxidant vitamin supplementation: a randomized trial in a high-risk population.
Plummer M; Vivas J; Lopez G; Bravo JC; Peraza S; Carillo E; Cano E; Castro D; Andrade O; Sánchez V; Garcia R; Buiatti E; Aebischer C; Franceschi S; Oliver W; Muñoz N
J Natl Cancer Inst; 2007 Jan; 99(2):137-46. PubMed ID: 17227997
[TBL] [Abstract][Full Text] [Related]
14. The efficiency and safety of high-dose vitamin C in patients with COVID-19: a retrospective cohort study.
Gao D; Xu M; Wang G; Lv J; Ma X; Guo Y; Zhang D; Yang H; Jiang W; Deng F; Xia G; Lu Z; Lv L; Gong S
Aging (Albany NY); 2021 Feb; 13(5):7020-7034. PubMed ID: 33638944
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of vitamin C: insights into the oral and intravenous administration of ascorbate.
Duconge J; Miranda-Massari JR; Gonzalez MJ; Jackson JA; Warnock W; Riordan NH
P R Health Sci J; 2008 Mar; 27(1):7-19. PubMed ID: 18450228
[TBL] [Abstract][Full Text] [Related]
16. Long-term, low-dose, intravenous vitamin C leads to plasma calcium oxalate supersaturation in hemodialysis patients.
Canavese C; Petrarulo M; Massarenti P; Berutti S; Fenoglio R; Pauletto D; Lanfranco G; Bergamo D; Sandri L; Marangella M
Am J Kidney Dis; 2005 Mar; 45(3):540-9. PubMed ID: 15754276
[TBL] [Abstract][Full Text] [Related]
17. Vitamin C and cancer: what can we conclude--1,609 patients and 33 years later?
Cabanillas F
P R Health Sci J; 2010 Sep; 29(3):215-7. PubMed ID: 20799507
[TBL] [Abstract][Full Text] [Related]
18. A pilot clinical study of continuous intravenous ascorbate in terminal cancer patients.
Riordan HD; Casciari JJ; González MJ; Riordan NH; Miranda-Massari JR; Taylor P; Jackson JA
P R Health Sci J; 2005 Dec; 24(4):269-76. PubMed ID: 16570523
[TBL] [Abstract][Full Text] [Related]
19. Vitamins and quality of life in hemodialysis patients.
Mydlik M; Derzsiová K
J Nephrol; 2008; 21 Suppl 13():S129-33. PubMed ID: 18446746
[TBL] [Abstract][Full Text] [Related]
20. High-dose vitamin C management in dapsone-induced methemoglobinemia.
Park SY; Lee KW; Kang TS
Am J Emerg Med; 2014 Jun; 32(6):684.e1-3. PubMed ID: 24439259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
